Nemaura Medical (NMRD) 10-Q2023 Q2 Quarterly report

Filed: 14 Nov 22, 5:23pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. junior Avg

New words: abandoned, allocated, applying, asset, assurance, Australia, award, beginning, bring, China, Codification, collectively, compliance, default, deficiency, distinct, enacted, enactment, EVERSANA, evidence, exceed, extension, extent, force, highly, impairment, infrastructure, inherently, intangible, IP, judgment, lesser, maximum, molding, occurrence, owed, pending, promise, provision, realize, realized, regularly, royalty, satisfied, scheme, selected, significantly, suffered, taxable, temporary, typically, unamortized, uncertain, unpredictable, Uptown, valuation, variable

Removed: adequate, amounting, August, Black, Care, charged, comprising, convert, director, fall, fixed, lieu, NDM, obligated, occurred, participation, periodic, predominantly, prepaid, repayment, stockholder, surcharge, treated, white

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

NMRD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION

Pursuant to 18 U.S.C. 1350 as adopted by Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, Dewan F.H. Chowdhury, Chief Executive Officer, President and Interim Chief Financial Officer of Nemaura Medical Inc. (the “Company”), has executed this certification in connection with the filing with the Securities and Exchange Commission of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2022 (the “Report”).

The undersigned hereby certifies that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company

Date: November 14, 2022	/s/ Dewan F.H. Chowdhury
	Dewan F.H. Chowdhury Chief Executive Officer, Interim Chief Financial Officer, and President (Principal Executive Officer and Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.